News Focus
News Focus
Followers 29
Posts 695
Boards Moderated 0
Alias Born 07/26/2017

Re: skitahoe post# 431243

Saturday, 01/01/2022 8:31:02 PM

Saturday, January 01, 2022 8:31:02 PM

Post# of 817835
LP has always viewed L and D as platform technologies and once L is approved in the hardest to treat cancer the gloves are off and she will be shooting for a valuation no less than 50 Billion which would still be cheap. The challenge will be reaching a minimum of $20 out the gate which I think can be achieved with the plan that seems to be coming together. If we reach that target and Merck is blown away by the results of the UCLA trial my thinking is LP will be shooting for that minimum of $50. Good luck to all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News